Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes-Reference-Cited by-同舟云学术

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes

Published:2013-08-26 Issue:16 Volume:73 Page:1824-1835
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Ren Shancheng¹,Xu Jianfeng²³⁴,Zhou Tie¹,Jiang Haowen²,Chen Haitao³,Liu Fang²³,Na Rong²,Zhang Limin²,Wu Yishuo²,Sun Jielin⁴,Yang Bo¹,Gao Xu¹,Zheng S. Lilly⁴,Xu Chuanliang¹,Ding Qiang²,Sun Yinghao¹

Affiliation:

1. Department of Urology; Shanghai Changhai Hospital; Second Military Medical University; Shanghai China

2. Fudan Institute of Urology; Huashan Hospital; Fudan University; Shanghai China

3. State Key Laboratory of Genetic Engineering; Center for Genetic Epidemiology; School of Life Sciences; Fudan University; Shanghai China

4. Center for Cancer Genomics; Wake Forest University School of Medicine; Winston-Salem North Carolina

Publisher

Wiley

Subject

Urology,Oncology

Reference53 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Prostate cancer risk-associated genetic markers and their potential clinical utility;Xu;Asian J Androl,2013

3. A systematic review and meta-analysis of familial prostate cancer risk;Johns;BJU Int,2003

4. Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis;Bruner;Int J Cancer,2003

5. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma. A meta-analysis;Zeegers;Cancer,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic evaluation of narrow‐sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort;Clinical Genetics;2023-03-06

2. The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy;Journal of Clinical Medicine;2023-02-08

3. The role of genetic testing in prostate cancer screening, diagnosis, and treatment;Current Opinion in Oncology;2022-05

4. Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies;Prostate Cancer and Prostatic Diseases;2022-03-28

5. Prediction of clinically significant prostate cancer using polygenic risk models in Asians;Investigative and Clinical Urology;2022